BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X, Tian SB, Yan C. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0142080. [PMID: 26556485 DOI: 10.1371/journal.pone.0142080] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol 2020;11:90. [PMID: 32117120 DOI: 10.3389/fmicb.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther 2018;47:494-503. [PMID: 29243850 DOI: 10.1111/apt.14471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
3 den Hoed CM, Kuipers EJ. Gastric Cancer: How Can We Reduce the Incidence of this Disease? Curr Gastroenterol Rep. 2016;18:34. [PMID: 27184043 DOI: 10.1007/s11894-016-0506-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
4 Wang Y, Zhu Z, Liu Z, Zhao Z, Xue X, Li X, Li P, Rong G, Ma Y. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer. J Int Med Res 2020;48:300060520914826. [PMID: 32228342 DOI: 10.1177/0300060520914826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fann JC, Chiang TH, Yen AM, Lee YC, Wu MS, Chen HH. Personalized risk assessment for dynamic transition of gastric neoplasms. J Biomed Sci 2018;25:84. [PMID: 30453970 DOI: 10.1186/s12929-018-0485-6] [Reference Citation Analysis]
6 Liu L, Lang J, Jin Y, Chen Y, Chang W, Yao Y, Yu J. The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2019;2019:7087232. [PMID: 30804996 DOI: 10.1155/2019/7087232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study. BMC Gastroenterol 2021;21:264. [PMID: 34118868 DOI: 10.1186/s12876-021-01794-6] [Reference Citation Analysis]
8 Luu MN, Quach DT, Hiyama T. Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy? Asia Pac J Clin Oncol 2021. [PMID: 34811928 DOI: 10.1111/ajco.13704] [Reference Citation Analysis]
9 Fock KM, Ang TL. Editorial: risk stratification for endoscopic surveillance of metachronous gastric cancer after endoscopic resection. Aliment Pharmacol Ther 2017;46:1014-5. [PMID: 29052852 DOI: 10.1111/apt.14322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Krilaviciute A, Stock C, Leja M, Brenner H. Potential of non-invasive breath tests for preselecting individuals for invasive gastric cancer screening endoscopy. J Breath Res 2018;12:036009. [DOI: 10.1088/1752-7163/aab5be] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, Khan MN, Lan L, Jia CH, Zhang YR, Ding SZ. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol 2020; 26(25): 3673-3685 [PMID: 32742135 DOI: 10.3748/wjg.v26.i25.3673] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
13 Waddingham W, Nieuwenburg SAV, Carlson S, Rodriguez-Justo M, Spaander M, Kuipers EJ, Jansen M, Graham DG, Banks M. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol 2021;12:322-31. [PMID: 34249318 DOI: 10.1136/flgastro-2018-101089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Ekheden I, Yang X, Chen H, Chen X, Yuan Z, Jin L, Lu M, Ye W. Associations Between Gastric Atrophy and Its Interaction With Poor Oral Health and the Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Region of China: A Population-Based Case-Control Study. Am J Epidemiol 2020;189:931-41. [PMID: 31899792 DOI: 10.1093/aje/kwz283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Botezatu A, Bodrug N. Chronic atrophic gastritis: an update on diagnosis. Med Pharm Rep 2021;94:7-14. [PMID: 33629042 DOI: 10.15386/mpr-1887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
17 Lahner E, Brigatti C, Marzinotto I, Carabotti M, Scalese G, Davidson HW, Wenzlau JM, Bosi E, Piemonti L, Annibale B, Lampasona V. Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients. Clin Transl Gastroenterol 2017;8:e215. [PMID: 28102858 DOI: 10.1038/ctg.2016.71] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
18 In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M. Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. Cancer Epidemiol Biomarkers Prev 2022;31:1426-32. [PMID: 35534235 DOI: 10.1158/1055-9965.EPI-21-1328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Calanzani N, Druce PE, Snudden C, Milley KM, Boscott R, Behiyat D, Saji S, Martinez-Gutierrez J, Oberoi J, Funston G, Messenger M, Emery J, Walter FM. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Adv Ther 2021;38:793-834. [PMID: 33306189 DOI: 10.1007/s12325-020-01571-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
20 Leja M, Kortelainen JM, Polaka I, Turppa E, Mitrovics J, Padilla M, Mochalski P, Shuster G, Pohle R, Kashanin D, Klemm R, Ikonen V, Mezmale L, Broza YY, Shani G, Haick H; SniffPhone Project Research Group. Sensing gastric cancer via point-of-care sensor breath analyzer. Cancer 2021;127:1286-92. [PMID: 33739456 DOI: 10.1002/cncr.33437] [Reference Citation Analysis]
21 Nieminen A, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Scand J Gastroenterol. 2019;54:145-151. [PMID: 30700174 DOI: 10.1080/00365521.2019.1566492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
22 Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Uchida T, Yamaoka Y. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer. 2019;22:104-112. [PMID: 29934751 DOI: 10.1007/s10120-018-0844-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
23 Zhao C, Li P, Zhang L, Wang B, Xiao L, Guo F, Wei Y. An Observational Study on Aberrant Methylation of Runx3 With the Prognosis in Chronic Atrophic Gastritis Patients. Medicine (Baltimore) 2016;95:e3356. [PMID: 27196446 DOI: 10.1097/MD.0000000000003356] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Sun L, Tu H, Chen T, Yuan Q, Liu J, Dong N, Yuan Y. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer. Sci Rep 2017;7:11621. [PMID: 28912586 DOI: 10.1038/s41598-017-12022-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
25 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 170] [Cited by in F6Publishing: 142] [Article Influence: 56.7] [Reference Citation Analysis]
26 Libânio D, Ortigão R, Pimentel-nunes P, Dinis-ribeiro M. Improving the Diagnosis and Treatment of Early Gastric Cancer in the West. GE Port J Gastroenterol. [DOI: 10.1159/000520529] [Reference Citation Analysis]
27 Bizzaro N, Bagnasco M, Tozzoli R, Brusca I, Cinquanta L, Tampoia M, Deleonardi G, Antico A, Pesce G, Alessio MG, Liguori M, Bassetti D, Villalta D. Choosing Wisely in autoimmunologia: le 5 Proposte del Gruppo di Studio in Autoimmunologia della SIPMeL. Riv Ital Med Lab 2018;14:11-9. [DOI: 10.1007/s13631-018-0181-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
28 Tong Y, Wu Y, Song Z, Yu Y, Yu X. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. BMC Gastroenterol 2017;17:88. [PMID: 28728545 DOI: 10.1186/s12876-017-0641-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
29 Huang YK, Kang WM, Ma ZQ, Liu YQ, Zhou L, Yu JC. Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults. Medicine (Baltimore) 2016;95:e4730. [PMID: 27583914 DOI: 10.1097/MD.0000000000004730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
30 Yao K, Uedo N, Kamada T, Hirasawa T, Nagahama T, Yoshinaga S, Oka M, Inoue K, Mabe K, Yao T, Yoshida M, Miyashiro I, Fujimoto K, Tajiri H. Guidelines for endoscopic diagnosis of early gastric cancer. Dig Endosc. 2020;32:663-698. [PMID: 32275342 DOI: 10.1111/den.13684] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
31 Wang L, Li J, Xiong X, Hao T, Zhang C, Gao Z, Zhong L, Zhao Y. Volatile organic compounds as a potential screening tool for neoplasm of the digestive system: a meta-analysis. Sci Rep 2021;11:23716. [PMID: 34887450 DOI: 10.1038/s41598-021-02906-8] [Reference Citation Analysis]
32 Song JH, Kim SG, Jin EH, Lim JH, Yang SY. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy. Gut Liver 2017;11:612-9. [PMID: 28531911 DOI: 10.5009/gnl16488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
33 Wang M, Wang J, Jiang H. Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer. Oncol Lett 2019;17:3227-32. [PMID: 30867753 DOI: 10.3892/ol.2019.9957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Jiang W, Sun G, Zhang Y, Hu Z, Wen X, Men S, Xing Z, Zhang S, Huang B, Wang C. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection. J Clin Lab Anal 2020;34:e23287. [PMID: 32147885 DOI: 10.1002/jcla.23287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Castro C, Dinis-Ribeiro M, Rodrigues ANG, Calheiros T, Santos J, Pereira P, Ramos M, Cunha H, Andrade M, Costa A, Sá L, Antunes L, Bento MJ, Lomba-Viana R. Western long-term accuracy of serum pepsinogen-based gastric cancer screening. Eur J Gastroenterol Hepatol 2018;30:274-7. [PMID: 29215432 DOI: 10.1097/MEG.0000000000001040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Xu Y, Miremadi A, Link A, Malfertheiner P, Fitzgerald RC, Bornschein J. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study. J Clin Pathol 2019;72:825-9. [PMID: 31235543 DOI: 10.1136/jclinpath-2019-205700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Li H, Wang F, Ge S, Liu H, Yan M, Yu J. Turning Nonspecific Interference into Signal Amplification: Covalent Biosensing Nanoassembly Enabled by Metal-Catalyzed Cross-Coupling. Anal Chem 2017;89:6834-9. [DOI: 10.1021/acs.analchem.7b01269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46:657-667. [PMID: 28782119 DOI: 10.1111/apt.14248] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
39 Tan MC, Jamali T, Nguyen TH, Galvan A, Sealock RJ, Khan A, Zarrin-Khameh N, Holloman A, Kampagianni O, Ticas DH, Liu Y, El-Serag HB, Thrift AP. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol 2021. [PMID: 34908535 DOI: 10.14309/ajg.0000000000001576] [Reference Citation Analysis]
40 Song Y, Liu X, Cheng W, Li H, Zhang D. The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019. Sci Rep 2022;12:11542. [PMID: 35798837 DOI: 10.1038/s41598-022-15839-7] [Reference Citation Analysis]
41 Huang ZB, Zhang HT, Yu B, Yu DH. Cell-free DNA as a liquid biopsy for early detection of gastric cancer. Oncol Lett 2021;21:3. [PMID: 33240409 DOI: 10.3892/ol.2020.12264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Chiang TH, Chiu SY, Chen SL, Yen AM, Fann JC, Liu CY, Chou CK, Chiu HM, Shun CT, Wu MS, Lin JT, Lee YC, Chen TH, Lin MW. Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study. J Clin Gastroenterol. 2019;53:e186-e193. [PMID: 29369241 DOI: 10.1097/mcg.0000000000000992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
43 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study. Front Oncol 2021;11:652574. [PMID: 34504781 DOI: 10.3389/fonc.2021.652574] [Reference Citation Analysis]
44 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology 2020;158:732-744.e16. [PMID: 31816301 DOI: 10.1053/j.gastro.2019.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
46 Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS. Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays. Helicobacter 2017;22. [PMID: 28557128 DOI: 10.1111/hel.12393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
47 Nieuwenburg SAV, Mommersteeg MC, Eikenboom EL, Yu B, den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Burger JPW, Bruno MJ, Fuhler GM, Peppelenbosch MP, Doukas M, Kuipers EJ, Spaander MCW. Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study. Endosc Int Open 2021;9:E297-305. [PMID: 33655025 DOI: 10.1055/a-1314-6626] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
48 Ota M, Tahara T, Otsuka T, Jing W, Nomura T, Hayashi R, Shimasaki T, Nakamura M, Shibata T, Arisawa T. Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility. Oncol Lett 2018;15:3772-8. [PMID: 29467894 DOI: 10.3892/ol.2018.7785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bang CS, Lee JJ, Baik GH. Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14240. [PMID: 30681610 DOI: 10.1097/MD.0000000000014240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
50 Shen S, Jiang J, Yuan Y. Pepsinogen C expression, regulation and its relationship with cancer. Cancer Cell Int 2017;17:57. [PMID: 28546787 DOI: 10.1186/s12935-017-0426-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
51 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 67] [Article Influence: 15.5] [Reference Citation Analysis]
52 Mezmale L, Isajevs S, Bogdanova I, Polaka I, Krigere A, Rudzite D, Rudule A, Kikuste I, Parshutin S, Tazhedinov A, Mushinskiy D, Sametayev D, Belikhina T, Igissinov N, Park JY, Herrero R, Leja M. Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy. Asian Pac J Cancer Prev 2019;20:3825-9. [PMID: 31870128 DOI: 10.31557/APJCP.2019.20.12.3825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Yang Z, Yan L, Xie P, Hu P, Zhao W, Lu Y, Xing X, Liu X. Association of Serum Pepsinogens With Esophageal Squamous Cell Carcinoma Risk: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:928672. [DOI: 10.3389/fonc.2022.928672] [Reference Citation Analysis]
54 Razuka-ebela D, Polaka I, Daugule I, Parshutin S, Santare D, Ebela I, Rudzite D, Vangravs R, Herrero R, Young Park J, Leja M. Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study. Diagnostics 2022;12:1166. [DOI: 10.3390/diagnostics12051166] [Reference Citation Analysis]
55 Kotelevets SM, Chekh SA. Screening, Monitoring, and Treatment of Precancerous Atrophic Gastritis in the Prospective Study for Seven Years. Asian Pac J Cancer Prev. 2020;21:331-336. [PMID: 32102507 DOI: 10.31557/apjcp.2020.21.2.331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Zhou MJ, Huang RJ. Catching Up with the World: Pepsinogen Screening for Gastric Cancer in the United States. Cancer Epidemiol Biomarkers Prev 2022;31:1257-8. [PMID: 35775231 DOI: 10.1158/1055-9965.EPI-22-0372] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
58 Leja M, Park JY, Murillo R, Liepniece-Karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R. Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study. BMJ Open 2017;7:e016999. [PMID: 28801429 DOI: 10.1136/bmjopen-2017-016999] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
59 Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Mansour-Ghanaei F, Joukar F, Baghaee M, Sepehrimanesh M, Hojati A. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer. Biomol Concepts 2019;10:82-90. [PMID: 31188744 DOI: 10.1515/bmc-2019-0010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
61 Takagi A, Yanagi H, Ozawa H, Uemura N, Nakajima S, Inoue K, Kawai T, Ohtsu T, Koga Y. Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial. Gastroenterol Res Pract 2016;2016:7490452. [PMID: 27478434 DOI: 10.1155/2016/7490452] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
62 Faria L, Silva JC, Rodríguez-carrasco M, Pimentel-nunes P, Dinis-ribeiro M, Libânio D. Gastric cancer screening: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2022.2068966] [Reference Citation Analysis]
63 Huang Y, Kang W, Ma Z, Liu Y, Zhou L, Yu J. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Carcinogenesis 2019;40:370-9. [DOI: 10.1093/carcin/bgy142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
64 Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6-30. [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288] [Cited by in Crossref: 1424] [Cited by in F6Publishing: 1169] [Article Influence: 284.8] [Reference Citation Analysis]
65 Lahner E, Marzinotto I, Lampasona V, Dottori L, Bazzigaluppi E, Brigatti C, Secchi M, Piemonti L, Conti L, Pilozzi E, Davidson HW, Wenzlau JM, Annibale B. Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis. Clin Transl Gastroenterol 2020;11:e00240. [PMID: 33031196 DOI: 10.14309/ctg.0000000000000240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
66 Zhao AJ, Qian YY, Sun H, Hou X, Pan J, Liu X, Zhou W, Chen YZ, Jiang X, Li ZS, Liao Z. Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals. Gastrointest Endosc. 2018;88:466-474.e1. [PMID: 29753039 DOI: 10.1016/j.gie.2018.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
67 Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: A global perspective. J Gastroenterol Hepatol 2020;35:1495-502. [PMID: 32181516 DOI: 10.1111/jgh.15037] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
68 Chen X, Yang Y, Liu J, Li B, Xu Y, Li C, Xu Q, Liu G, Chen Y, Ying J, Duan S. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Oncotarget 2017;8:8105-19. [PMID: 28042954 DOI: 10.18632/oncotarget.14099] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
69 Liu C, Chen C, Lai H, Liang H, Zhong S, Guo G, Wang L, Li L, Hussein AF. A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay). Computational and Mathematical Methods in Medicine 2022;2022:1-7. [DOI: 10.1155/2022/1704948] [Reference Citation Analysis]
70 Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2020;158:693-702. [PMID: 31816298 DOI: 10.1053/j.gastro.2019.12.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 16.7] [Reference Citation Analysis]
71 So JBY, Kapoor R, Zhu F, Koh C, Zhou L, Zou R, Tang YC, Goo PCK, Rha SY, Chung HC, Yoong J, Yap CT, Rao J, Chia CK, Tsao S, Shabbir A, Lee J, Lam KP, Hartman M, Yong WP, Too HP, Yeoh KG. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 2021;70:829-37. [PMID: 33028667 DOI: 10.1136/gutjnl-2020-322065] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 27.0] [Reference Citation Analysis]
72 Hu W, Zheng W, Liu Q, Chu H, Chen S, Kim JJ, Wu J, Si J. Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis. Oncotarget 2017;8:113142-52. [PMID: 29348893 DOI: 10.18632/oncotarget.22613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
73 Yu TY, Wei JN, Kuo CH, Liou JM, Lin MS, Shih SR, Hua CH, Hsein YC, Hsu YW, Chuang LM, Lee MK, Hsiao CH, Wu MS, Li HY. The Impact of Gastric Atrophy on the Incidence of Diabetes. Sci Rep 2017;7:39777. [PMID: 28045079 DOI: 10.1038/srep39777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Chen L, Hong J, Hu R, Yu X, Chen X, Zheng S, Qin Y, Zhou X, Wang Y, Zheng L, Fang H, Liu P, Huang B. Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis. Cancer Manag Res 2021;13:7759-69. [PMID: 34675671 DOI: 10.2147/CMAR.S328312] [Reference Citation Analysis]
75 Alikhani M, Saberi S, Esmaeili M, Michel V, Tashakoripour M, Abdirad A, Aghakhani A, Eybpoosh S, Vosough M, Mohagheghi MA, Eshagh Hosseini M, Touati E, Mohammadi M. Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer. Iran Biomed J 2021;25:323-33. [PMID: 34425651 DOI: 10.52547/ibj.25.5.323] [Reference Citation Analysis]
76 Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study. BMJ Open 2019;9:e032013. [PMID: 31537576 DOI: 10.1136/bmjopen-2019-032013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]